MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

08 May 2023 Evaluate
The Sales for the quarter ended March 2023 of Rs. -0.10 million declined by -94.35% from Rs. -1.77 millions.The Net Loss for the quarter ended March 2023 is Rs. -1.97 millions as compared to Net Loss of Rs. -2.31 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to -1.97% as compared to -2.31% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales -0.10 -1.77 -94.35 8.28 21.62 -61.70 8.28 21.62 -61.70
Other Income 0.00 0.07 0.00 0.00 0.07 0.00 0.00 0.07 0.00
PBIDT -1.97 -2.31 -14.72 4.56 -0.08 -5800.00 4.56 -0.08 -5800.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.97 -2.31 -14.72 4.56 -0.08 -5800.00 4.56 -0.08 -5800.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -1.97 -2.31 -14.72 4.56 -0.08 -5800.00 4.56 -0.08 -5800.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.97 -2.31 -14.72 4.56 -0.08 -5800.00 4.56 -0.08 -5800.00
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 1970.00 130.51 1409.48 55.07 -0.37 -14984.46 55.07 -0.37 -14984.46
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..